GT Biopharma Balance Sheet (2010-2026)

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Balance Sheet	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Receivables - Accured (Quarter)		26.03M
Assets
Current Assets
Cash & Equivalents (Quarter)	39.51M	3.90M	8.97M	7.30M	5.40M	2.46M	5.67M	1.80M	2.77M	16.00M	1.08M	1.80M	7.60M	6.42M	3.80M	2.20M	5.23M	2.10M	3.90M	7.00M
Receivables - Net (Quarter)
Receivables - Other (Quarter)											4.58M		0.86M		1.80M	1.90M	0.43M	1.90M	1.10M	1.00M
Receivables (Quarter)
Inventory (Quarter)
Prepaid Assets (Quarter)	0.06M	0.09M	0.19M	0.45M	0.22M	0.09M	0.05M	0.04M	0.05M	0.04M	0.08M	0.08M		0.25M	0.19M	0.20M	1.04M	0.94M	0.57M	0.41M
Current Assets (Quarter)	39.57M	35.80M	32.17M	27.19M	23.95M	20.87M	16.56M	19.94M	18.02M	16.05M	14.06M	9.88M		6.76M	4.23M	2.66M	7.12M	4.32M	8.11M	10.00M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter)
Goodwill (Quarter)
Intangibles (Quarter)
Goodwill & Intangibles (Quarter)
Long-Term Deferred Tax (Quarter)
Other Non-Current Assets (Quarter)				0.01M	0.01M	0.01M	0.01M	0.01M	0.01M	0.01M
Non-Current Assets (Quarter)				0.25M	0.22M	0.20M	0.17M	0.15M	0.12M	0.10M	0.05M	0.03M
Assets (Quarter)	39.57M	35.80M	32.17M	27.44M	24.17M	21.07M	16.74M	20.09M	18.14M	16.15M	14.11M	9.91M		6.76M	4.23M	2.66M	7.12M	4.32M	8.11M	10.00M
Liabilities
Current Liabilities
Accounts Payables (Quarter)	1.50M	2.80M	8.19M	8.11M	0.82M	3.33M	3.14M	3.13M	3.50M	1.12M	4.33M	1.23M		2.61M	3.85M	2.38M	1.37M	0.77M	0.75M	0.25M
Notes Payables (Quarter)	0.84M	0.34M	0.14M	0.12M	0.12M	0.06M	0.02M	2.93M	1.54M	1.05M	1.05M	0.39M
Dividends payables (Quarter)																	0.09M	0.14M
Payables (Quarter)	2.34M	3.14M	8.33M	8.23M	0.94M	3.38M	3.16M	6.06M	5.04M	2.17M	5.38M	1.62M		2.61M	3.85M	2.38M	1.46M	0.91M	0.75M	0.25M
Accumulated Expenses (Quarter)	0.91M	0.75M	1.90M	1.17M	1.13M	1.54M	1.67M	0.83M	1.22M	1.03M	1.20M	0.96M	0.86M	1.87M	1.80M	1.13M	0.61M	0.40M	1.56M	2.16M
Short term Debt (Quarter)			0.03M
Current Leases (Quarter)				0.10M	0.10M	0.11M	0.11M	0.12M	0.12M	0.09M	0.06M	0.03M
Current Deferred Revenue (Quarter)
Total Current Liabilities (Quarter)	3.28M	3.92M	10.26M	9.50M	8.61M	5.03M	4.94M	4.08M	4.84M	5.09M	6.63M	4.60M		4.66M	5.90M	3.64M	31.04M	1.32M	2.32M	2.42M
Non-Current Liabilities
Non-Current Debt (Quarter)	0.03M	0.03M
Convertible Debt (Quarter)
Preferred Stock Liabilities (Quarter)																	1.96M
Minority Interest (Quarter)
Operating Leases (Quarter)				0.15M	0.12M	0.09M	0.06M	0.03M			58.00M	0.03M
Other Non-Current Liabilities (Quarter)							0.02M	2.93M	1.54M	1.10M	1.05M	0.39M	0.28M
Total Non-Current Liabilities (Quarter)							4.98M	4.11M	4.84M	5.04M	5.58M	4.21M	-0.28M
Total Liabilities (Quarter)	39.57M	35.80M	10.26M	9.65M	8.73M	5.12M	5.00M	7.03M	6.38M	6.14M	6.63M	4.60M		6.76M	4.23M	2.66M	31.04M	1.32M	8.11M	10.00M
Shareholder's Equity
Total Debt (Quarter)	0.03M	0.03M	0.03M
Common Equity (Quarter)	36.29M	31.88M	21.91M	17.79M	15.44M	15.95M	11.73M	13.05M	11.76M	10.01M	7.48M	5.31M	5.51M	2.10M	-1.67M	-0.98M	-25.88M	3.00M	5.79M	7.58M
Liabilities and Shareholders Equity (Quarter)	39.57M	35.80M	32.17M	27.44M	24.17M	21.07M	16.74M	20.09M	18.14M	16.15M	14.11M	9.91M		6.76M	4.23M	2.66M	7.12M	4.32M	8.11M	10.00M
Retained Earnings (Quarter)	655.65M	-635.39M	674.35M	-659.02M	677.41M	684.80M	686.17M	-674.70M	688.41M	689.07M	-682.07M	689.64M		-691.45M	693.55M	695.02M	700.38M	-718.10M	729.66M	-726.84M
Preferred Shares (Quarter)			0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M		0.00M	0.00M	0.00M	0.00M	0.00M	0.00M	0.00M
Treasury Shares (Quarter)				0.19M		0.63M	0.28M	0.05M			0.01M	0.00M					0.01M

Research Tools

Datasets

Plans

Developers

GT Biopharma GTBP Balance Sheet (2010-2026)

Research Tools

Datasets

Plans

Developers

GT Biopharma GTBP Balance Sheet (2010-2026)

Create an account

Sign In

Reset Password